Help me find one treatment
Scientists say that the reference study means that they now have a much clearer picture of the main genetic factors of the disease. In addition to opening up new opportunities for treatment, it could allow doctors to develop a test precisely for the risk of Alzheimer before the onset of symptoms.
Researcher Dr Rebecca Sims of Cardiff University and the Dementia Research Institute in the UK said: “This study greatly doubles the number of genes identified that influence the risk for the more common form of the disease. Alzheimer. It offers exciting new targets for therapeutic intervention and develops our ability to develop algorithms that predict who will develop Alzheimer’s later. ”
The study, published in Nature Genetics, identified 75 genes associated with a higher risk of developing Alzheimer’s, including 42 that were previously unknown. Scientists have compared ADN100,000 people with the disease and compared them to over 600,000 healthy adults. They have already used the findings to identify the likelihood that someone with brain loss will develop Alzheimer’s in the next three years.
One million people in the UK will live with dementia in just three years. Despite being the biggest killer in the UK, there isn’t one yet treatment effective in fighting the disease, according to The Sun.
A useful study
Researcher Julie Williams, Center Director at the Dementia Research Institute in the UK at Cardiff University, said: “This is a benchmark study in Alzheimer’s research and is the culmination of 30 years of work. Genetics has helped us and will continue to help us identify the specific mechanisms of the disease that we can target therapeutically. This piece of work is a major leap in our mission to understand Alzheimer’s disease and, ultimately, to produce more treatments needed to delay or prevent the disease. “
Dr Susan Kohlhaas, research director at Alzheimer’s Research UK, said: “Eyelashes are the lifeblood. Previous genetic findings support much of our understanding of Alzheimer’s disease and the direction of research into new treatments. Creating an extensive list of risk genes for Alzheimer’s disease is like putting together the edge pieces of a puzzle, and while that doesn’t give us a complete picture, it does provide a valuable framework for future developments. “
–
